Literature DB >> 13994748

Vi-negative strains of Salmonella typhosa: attempts to induce W-V reversion and the use of non-Vi strains in evaluating typhoid vaccines.

J G TULLY, J A CURRIE.   

Abstract

Tully, Joseph G. (Walter Reed Army Institute of Research, Washington, D.C.) and Julius A. Currie. Vi-negative strains of Salmonella typhosa: attempts to induce W-V reversion and the use of non-Vi strains in evaluating typhoid vaccines. J. Bacteriol. 84:747-753. 1962.-Repeated attempts have been made to detect reversion of several W-form Salmonella typhosa strains to Vi antigen-containing cultures. Passage of the O-901, H-901, and Ty2W cultures through various mouse strains did not result in the recovery of V-form typhoid bacilli. Rabbits immunized repeatedly with non-Vi strains of typhoid bacilli, or with W cultures successively passed through mice, did not respond with Vi antibody formation. Attempts also were made to detect reversion of non-Vi strains passed in broth and plate cultures to which heat-killed Vi antigen-containing strains had been added. No evidence was obtained that the selection of Vi-containing cultures had been enhanced. The non-Vi typhoid strains employed in this study thus appeared to be stable W-form cultures. Viable-cell vaccines and acetone-killed and dried (AKD) vaccines of V- and W-form S. typhosa were compared in active mouse protection tests against intraperitoneal and intracerebral challenges with V- and W-form typhoid strains. Only Vi-containing cultures effectively protected mice against virulent V-form challenges, regardless of the route utilized. Greater quantities of both viable-cell and AKD vaccines prepared from non-Vi strains were required for protection against V- as well as W-form S. typhosa challenges.

Entities:  

Keywords:  ANTIGENS; SALMONELLA TYPHOSA

Mesh:

Substances:

Year:  1962        PMID: 13994748      PMCID: PMC277953          DOI: 10.1128/jb.84.4.747-753.1962

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  14 in total

1.  Comparison of intraperitoneal and intracerebral infective techniques for evaluating typhoid vaccines in mouse protection tests.

Authors:  J G TULLY; S GAINES
Journal:  Am J Hyg       Date:  1961-11

2.  A report on the laboratory assays carried out at the Lister Institute of Preventive Medicine on the typhoid vaccines used in the field study in Yugoslavia.

Authors:  A F STANDFAST
Journal:  Bull World Health Organ       Date:  1960       Impact factor: 9.408

3.  Comparison of intracerebral and intraperitoneal infective techniques for assaying mouse virulence of Salmonella typhosa strains.

Authors:  S GAINES; J G TULLY
Journal:  Am J Hyg       Date:  1961-07

4.  Enhancement of the mouse virulence of a non-Vi variant of Salmonella typhosa by Vi antigen.

Authors:  S GAINES; J G TULLY; W D TIGERTT
Journal:  J Immunol       Date:  1961-05       Impact factor: 5.422

5.  H antigen of Salmonella typhosa.

Authors:  J G TULLY; S GAINES
Journal:  J Bacteriol       Date:  1961-06       Impact factor: 3.490

6.  Mouse challenge with Salmonella typhosa T 5501 in testing the potency of typhoid vaccines.

Authors:  N H FISEK; S GOREN; N AKYAY
Journal:  Bull World Health Organ       Date:  1959       Impact factor: 9.408

7.  W-V Variation induced in S-typhi, S. paratyphi C and Paracolobactrum ballerup.

Authors:  O FELSENFELD
Journal:  Proc Soc Exp Biol Med       Date:  1954-10

8.  The visual identification of V and W form colonies in Salmonella cultures.

Authors:  M LANDY
Journal:  Public Health Rep       Date:  1950-07-28       Impact factor: 2.792

9.  Experiments with Vi-negative strains of Salmonella typhi.

Authors:  A F STANDFAST
Journal:  Bull World Health Organ       Date:  1960       Impact factor: 9.408

10.  Studies on infection and immunity in experimental typhoid fever. I. Typhoid fever in chimpanzees orally infected with Salmonella typhosa.

Authors:  G EDSALL; S GAINES; M LANDY; W D TIGERTT; H SPRINZ; R J TRAPANI; A D MANDEL; A S BENENSON
Journal:  J Exp Med       Date:  1960-07-01       Impact factor: 14.307

View more
  2 in total

1.  Role of RpoS in fine-tuning the synthesis of Vi capsular polysaccharide in Salmonella enterica serotype Typhi.

Authors:  Javier Santander; Soo-Young Wanda; Cheryl A Nickerson; Roy Curtiss
Journal:  Infect Immun       Date:  2006-12-18       Impact factor: 3.441

2.  Regulation of Vi capsular polysaccharide synthesis in Salmonella enterica serotype Typhi.

Authors:  Javier Santander; Kenneth L Roland; Roy Curtiss
Journal:  J Infect Dev Ctries       Date:  2008-12-01       Impact factor: 0.968

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.